
Bromhexine Hydrochloride is a premium mucolytic active pharmaceutical ingredient (API) with CAS number 611-75-6. This high-purity respiratory compound is widely used to manufacture clinical-strength cough syrups, oral tablets, and secretolytic formulations that effectively clear deep bronchial mucus.
Exceptional digestibility and rapid absorption provide a major competitive advantage in the formulation of therapeutic treatments. This active pharmaceutical ingredient works by providing the essential structural mechanisms—specifically breaking down mucopolysaccharide fibers and increasing lysosomal activity—needed for effective bronchial passage modulation. It helps manufacturers achieve potent therapeutic profiles in anti-cough medical products without sacrificing formula stability. For instance, Bromhexine Hydrochloride is frequently used as a primary ingredient in clinical-strength secretolytic therapies. Consequently, it improves the clinical efficacy of acute respiratory tract disorder treatments. As a result, Zyntex ensures low heavy metal content and strict microbiological control for our supply, ensuring maximum safety during your manufacturing cycle.
Moreover, Zyntex supplies specialized micronized grades for the clinical medicine industry. This compound acts as a critical nutritional fortifier, helping to enhance the defense mechanisms of patients undergoing respiratory treatment protocols. It pushes the boundaries of medical science by offering a heat-stable active source that does not affect the final solution’s viscosity. At the same time, it serves as a crucial biomaterial in the synthesis of specialized prolonged-release matrices and pulmonary health tablets. In short, our product serves as a dependable “structural matrix.” It supports both the vitality of the human body and the precision of biomedical engineering.
Recently, scientific interest in its application for eco-friendly biodegradable therapeutic coatings and target-release granules has grown. It provides a natural and potent alternative to synthetic options in specific target delivery applications. Because of this, Zyntex offers refined chemical grades designed to meet the rigorous specifications of modern sustainable pharmaceutical research. Ultimately, choosing Zyntex secures a reliable and transparent chemical supply chain. We balance core chemistry expertise with rigorous quality monitoring. To conclude, our commitment ensures your Bromhexine Hydrochloride manufacturing processes achieve the highest levels of clinical performance and purity.
This high-purity bioavailable mucolytic is essential in these four primary sectors:
Primary active source for liquid oral suspensions and expectorant solutions. Thus, it provides essential support for localized mucus clearing.
Key chemical active utilized for solid dosage forms and effervescent blends. Undoubtedly, it is vital for maintaining uniform systemic dissolution rates.
Used for target lysosomal enzyme enhancement and viscosity reduction protocols. Consequently, it is vital for high-performance medical science.
Acts as a reliable therapeutic active in critical prescription formulations. Specifically, it supports rapid patient respiratory tract recovery and safety management.
| Parameter | Standard Value |
|---|---|
| Product Name | Bromhexine Hydrochloride (USP/EP Pharmaceutical Grade) |
| Assay / Purity | 99.0% – 101.0% (Dried Basis) |
| Appearance | White or almost white crystalline powder |
| CAS Number | 611-75-6 |
📝 Safety & Handling: Generally recognized as a potent mucolytic active compound. Therefore, store in a cool, dry place away from direct sunlight in an airtight container. Protect from moisture and excessive ambient humidity to preserve complete pharmaceutical stability. Use standard medical-grade PPE including dust masks, gloves, and lab protection during large-scale manufacturing handling. Always consult the Safety Data Sheet (SDS) for detailed storage and handling protocols.